学术探索
学术期刊
新闻热点
数据分析
智能评审

Current drug development portfolio for antimalarial therapies

被引：43
作者：
Biagini, GA
O'Neill, PM
Bray, PG
Ward, SA
机构：
[1] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[2] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England
[3] Univ Liverpool, Dept Pharmacol, Liverpool L69 7ZD, Merseyside, England
来源：
CURRENT OPINION IN PHARMACOLOGY | 2005年 / 5卷 / 05期
基金：
英国惠康基金;
关键词：
D O I：
10.1016/j.coph.2005.05.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In response to the emergence of parasite drug resistance to currently deployed antimalarials, the scientific community, in partnership with the pharmaceutical industry and public organizations, has fashioned an antimalarial drug development portfolio for the sustained development and registration of safe, effective and cheap antimalarial medicines. The management of this portfolio is being driven by MMV (Medicines for Malaria Venture), with a number of projects recently reaching the clinical end of this drug development pipeline.
引用
收藏
页码：473 / 478
页数：6
相关论文
共 32 条
[1]   Characterization of the choline carrier of Plasmodium falciparum:: a route for the selective delivery of novel antimalarial chugs [J].
Biagini, GA ;
Pasini, EM ;
Hughes, R ;
De Koning, HP ;
Vial, HJ ;
O'Neill, PM ;
Ward, SA ;
Bray, PG .
BLOOD, 2004, 104 (10) :3372-3377
[2]   Antimalarial chemotherapy: young guns or back to the future? [J].
Biagini, GA ;
O'Neill, PM ;
Nzila, A ;
Ward, SA ;
Bray, PG .
TRENDS IN PARASITOLOGY, 2003, 19 (11) :479-487
[3]   Heme binding contributes to antimalarial activity of bis-quaternary ammoniums [J].
Biagini, GA ;
Richier, E ;
Bray, PG ;
Calas, M ;
Vial, H ;
Ward, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2584-2589
[4]  
Breman JG, 2001, AM J TROP MED HYG, V64, P1
[5]  
DANN O, 1975, LIEBIGS ANN CHEM, V1, P160
[6]   SYNTHESIS AND ANTIPROTOZOAL ACTIVITY OF 2,5-BIS(4-GUANYLPHENYL)FURANS [J].
DAS, BP ;
BOYKIN, DW .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (04) :531-536
[7]  
Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004
[8]   Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro [J].
De, DY ;
Krogstad, FM ;
Cogswell, FB ;
Krogstad, DJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 55 (06) :579-583
[9]  
DELASHERAS FG, DRUGS PROTOZOAN PAR
[10]   Artemisinins target the SERCA of Plasmodium falciparum [J].
Eckstein-Ludwig, U ;
Webb, RJ ;
van Goethem, IDA ;
East, JM ;
Lee, AG ;
Kimura, M ;
O'Neill, PM ;
Bray, PG ;
Ward, SA ;
Krishna, S .
NATURE, 2003, 424 (6951) :957-961
1234